4//SEC Filing
Boston Megan 4
Accession 0001062993-23-013639
CIK 0001808898other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:13 PM ET
Size
5.1 KB
Accession
0001062993-23-013639
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2023-06-13+153,000→ 153,000 totalExercise: $0.23Exp: 2033-06-13→ Common Stock (153,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:13 PM ET
- Size
- 5.1 KB